Ardea Biosciences, Inc. (RDEA)

[surf1944]

7. Ardea Biosciences, Inc. (RDEA): Focuses on the discovery and development of small-molecule therapeutics for the treatment of gout and cancer in the United States. Market cap of $432.18M. Net insider shares purchased over the last six months at 495.55K, which is 2.16% of the company's 22.96M share float. The stock is a short squeeze candidate, with a short float at 7.87% (equivalent to 18.88 days of average volume). The stock has performed poorly over the last month, losing 19.27%.

http://seekingalpha.com/article/318045-16-healthcare-stocks-insiders-want-most?source=yahoo